Please wait...
About This Project
OncoSynergy, Inc.
The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
Recent Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
How does lung fluke travel from snail to crab to human?
Snails and crabs occupy the land-water ecotone across Africa, but very little is known about them. These...
Conservation Efforts to Protect Endangered Turtles of Sulawesi
Sulawesi, Indonesia, is home to many species found nowhere else on Earth. Although rich in biodiversity...
